SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank43
3Y CAGR-15.7%
5Y CAGR+5.7%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-15.7%/yr
Annual compound
5Y CAGR
+5.7%/yr
Recent deceleration
Percentile
P43
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 0.85% |
| 2024 | 35.53% |
| 2023 | 8.22% |
| 2022 | 1.41% |
| 2021 | 9.23% |
| 2020 | 0.64% |
| 2019 | -6.78% |
| 2018 | -4.37% |
| 2017 | -3.52% |
| 2016 | 21.06% |